Hudkins, RL; Marino, MJ; Williams, M. Cognition. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 29 Jan 2010; pp 15–60. 784 kB. https://doi.org/10.1002/0471266949.bmc242 #95
Currie, KS. Antianxiety Agents. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #82
Cappelli, A; Anzini, M; Castriconi, F; Grisci, G; Paolino, M; Braile, C; Biggio, G. Design, synthesis, and biological evaluation of imidazo[1,5-a]quinoline as highly potent ligands of central benzodiazepine receptors. J. Med. Chem., 14 Apr 2016, 59 (7), 3353–3372. 3.0 MB. https://doi.org/10.1021/acs.jmedchem.6b00034 #Flumazenil MS,NMR
Anzini, M; Valenti, S; Braile, C; Cappelli, A; Vomero, S; Alcaro, S; Biggio, G. New insight into the central benzodiazepine receptor–ligand interactions: Design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds. J. Med. Chem., 25 Aug 2011, 54 (16), 5694–5711. 4.9 MB. https://doi.org/10.1021/jm2001597 #3 LC,MS,NMR
Huang, Q; He, X; Ma, C; Liu, R; Yu, S; Dayer, CA; Wenger, GR; McKernan, R; Cook, JM. Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem., 1 Jan 2000, 43 (1), 71–95. 912 kB. https://doi.org/10.1021/jm990341r #2
Clayton, T. Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for α5 GABA(A)/BZ receptors. Ph. D. Thesis, University of Wisconsin-Milwaukee, 1 Dec 2012. 28.1 MB. #Flumazenil; Ro-15-1788